Thursday, August 20, 2026 SourcesAbout🌓
🇺🇸 US ▾
BREAKING
Latest

Moderna shares surge after it says experimental mRNA cancer treatment passed key test

PBS NewsHour ·
Moderna shares surge after it says experimental mRNA cancer treatment passed key test

Moderna and Merck are developing a treatment using an mRNA-based cancer vaccine called intismeran that is designed to be tailored to individual patients based on unique mutations within their tumors.

Read the full article on PBS NewsHour ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.pbs.org — the content belongs to PBS NewsHour.

This story in other outlets

More from PBS NewsHour

See all ›

More in Latest

See all ›